24 HOUR WU ALLOCATION
| Research | Percent |
|---|---|
|
CANCER |
59.77% |
|
PEPTIDOMIMETIC CD40L BINDING |
14.94% |
|
ENZYME DYNAMICS |
13.79% |
|
GRASPETIDE RING FORMATION |
11.49% |
7 DAY WU ALLOCATION
| Research | Percent |
|---|---|
|
ENZYME DYNAMICS |
31.06% |
|
PEPTIDOMIMETIC CD40L BINDING |
27.82% |
|
CANCER |
20.31% |
|
PLANT LIPID BIOSYNTHESIS MUTANTS |
12.46% |
|
ATSTP10 TRANSPORT SIMULATION |
4.95% |
|
GRASPETIDE RING FORMATION |
1.71% |
|
SUCROSE TRANSPORTER ATSUC1 |
1.71% |
12 WEEK WU ALLOCATION
| Research | Percent |
|---|---|
|
PEPTIDOMIMETIC CD40L BINDING |
30.68% |
|
ENZYME DYNAMICS |
27.48% |
|
CANCER |
23.98% |
|
PLANT LIPID BIOSYNTHESIS MUTANTS |
12.62% |
|
ATSTP10 TRANSPORT SIMULATION |
2.82% |
|
GRASPETIDE RING FORMATION |
.97% |
|
SUCROSE TRANSPORTER ATSUC1 |
.97% |
|
ALZHEIMERS |
.49% |